Haemonetics Stock Price on February 18, 2025
| HAE Stock | USD 65.52 0.41 0.62% |
Below is the normalized historical share price chart for Haemonetics extending back to May 10, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Haemonetics stands at 65.52, as last reported on the 16th of March 2025, with the highest price reaching 67.03 and the lowest price hitting 65.28 during the day.
If you're considering investing in Haemonetics Stock, it is important to understand the factors that can impact its price. Haemonetics holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had a -0.13 % return per unit of risk over the last 3 months. Haemonetics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Haemonetics' Standard Deviation of 2.6, risk adjusted performance of (0.09), and Market Risk Adjusted Performance of (0.58) to validate the risk estimate we provide.
At present, Haemonetics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 766.3 M, whereas Common Stock Total Equity is forecasted to decline to about 421 K. . At present, Haemonetics' Price To Free Cash Flows Ratio is projected to increase based on the last few years of reporting. Haemonetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of May 1991 | 200 Day MA 78.2567 | 50 Day MA 69.0576 | Beta 0.429 |
Haemonetics |
Sharpe Ratio = -0.126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HAE |
Estimated Market Risk
| 2.67 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Haemonetics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Haemonetics by adding Haemonetics to a well-diversified portfolio.
Price Book 3.6296 | Enterprise Value Ebitda 14.2009 | Price Sales 2.3965 | Shares Float 49.8 M | Wall Street Target Price 96.8 |
Haemonetics Main Headline on 18th of February 2025
Peregrine Capital Management LLC Has 11.07 Million Stock Hol... by thelincolnianonline.com
Peregrine Capital Management LLC raised its position in Haemonetics Co. by 1.7 percent during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 141,803 shares of the medical instruments suppliers stock after acquiring an additional 2,400 shares during the period. Peregrine Capital Management LLC owned
Haemonetics Valuation on February 18, 2025
It is possible to determine the worth of Haemonetics on a given historical date. On February 18, 2025 Haemonetics was worth 61.89 at the beginning of the trading date compared to the closed value of 64.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Haemonetics stock. Still, in general, we apply an absolute valuation method to find Haemonetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Haemonetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Haemonetics' related companies.
| Open | High | Low | Close | Volume | |
| 62.51 | 62.93 | 61.64 | 62.36 | 1,333,274 | |
02/18/2025 | 61.89 | 64.23 | 61.64 | 64.09 | 1,271,203 |
| 62.36 | 65.15 | 62.33 | 63.66 | 826,832 |
| Backtest Haemonetics | | | Haemonetics History | | | Haemonetics Valuation | Previous | Next |
Haemonetics Trading Date Momentum on February 18, 2025
| On February 19 2025 Haemonetics was traded for 63.66 at the closing time. Highest Haemonetics's price during the trading hours was 65.15 and the lowest price during the day was 62.33 . The net volume was 826.8 K. The overall trading history on the 19th of February contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 0.67% . The trading delta at closing time to current price is 0.64% . |
Haemonetics Fundamentals Correlations and Trends
By evaluating Haemonetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Haemonetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Haemonetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Haemonetics Stock history
Haemonetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Haemonetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Haemonetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Haemonetics stock prices may prove useful in developing a viable investing in Haemonetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 46.3 M | 42.5 M | |
| Net Income Applicable To Common Shares | 132.7 M | 139.3 M |
Haemonetics Quarterly Net Working Capital |
|
Haemonetics Stock Technical Analysis
Haemonetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Haemonetics Period Price Range
Low | March 16, 2025
| High |
0.00 | 0.00 |
Haemonetics cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Haemonetics March 16, 2025 Market Strength
Market strength indicators help investors to evaluate how Haemonetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Haemonetics shares will generate the highest return on investment. By undertsting and applying Haemonetics stock market strength indicators, traders can identify Haemonetics entry and exit signals to maximize returns
Haemonetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Haemonetics' price direction in advance. Along with the technical and fundamental analysis of Haemonetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Haemonetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | 0.0256 | |||
| Treynor Ratio | (0.59) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |